This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fulton, R Articles by Neil, J C Search for Related Content PubMed PubMed Citation Articles by Fulton, R Articles by Neil, J C

 Previous Article  |  Next Article 

J Virol. 1990 April; 64(4): 1675-1682

Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus.

Beatson Institute for Cancer Research, Bearsden, Glasgow, Scotland.

ABSTRACT

The long terminal repeat U3 sequences were determined for multiple feline leukemia virus proviruses isolated from naturally occurring T-cell tumors. Heterogeneity was evident, even among proviruses cloned from individual tumors. Proviruses with one, two, or three repeats of the long terminal repeat enhancer sequences coexisted in one tumor, while two proviruses with distinct direct repeats were found in another. The enhancer repeats are characteristic of retrovirus variants with accelerated leukemogenic potential and occur between -155 and -244 base pairs relative to the RNA cap site. The termini of the repeats occur at or near sequence features which have been recognized at other retrovirus recombinational junctions. In vitro footprint analysis of the feline leukemia virus enhancer revealed three major nuclear protein binding sites, located at consensus sequences for the simian virus 40 core enhancer, the nuclear factor 1 binding site, and an indirect repeat which is homologous to the PEA2 binding site in the polyomavirus enhancer. Only the simian virus 40 core enhancer sequence is present in all of the enhancer repeats. Cell type differences in binding activities to the three motifs may underlie the selective process which leads to outgrowth of viruses with specific sequence duplications.

This article has been cited by other articles:

• Chandhasin, C., Coan, P. N., Pandrea, I., Grant, C. K., Lobelle-Rich, P. A., Puetter, A., Levy, L. S. (2005). Unique Long Terminal Repeat and Surface Glycoprotein Gene Sequences of Feline Leukemia Virus as Determinants of Disease Outcome. J. Virol. 79: 5278-5287 [Abstract] [Full Text]  
• Chandhasin, C., Lobelle-Rich, P., Levy, L. S. (2004). Feline leukaemia virus LTR variation and disease association in a geographical and temporal cluster. J. Gen. Virol. 85: 2937-2942 [Abstract] [Full Text]  
• Nishigaki, K., Hanson, C., Thompson, D., Yugawa, T., Hisasue, M., Tsujimoto, H., Ruscetti, S. (2002). Analysis of the Disease Potential of a Recombinant Retrovirus Containing Friend Murine Leukemia Virus Sequences and a Unique Long Terminal Repeat from Feline Leukemia Virus. J. Virol. 76: 1527-1532 [Abstract] [Full Text]  
• Ghosh, S. K., Faller, D. V. (1999). Feline Leukemia Virus Long Terminal Repeat Activates Collagenase IV Gene Expression through AP-1. J. Virol. 73: 4931-4940 [Abstract] [Full Text]  
• Chen, H., Bechtel, M. K., Shi, Y., Phipps, A., Mathes, L. E., Hayes, K. A., Roy-Burman, P. (1998). Pathogenicity Induced by Feline Leukemia Virus, Rickard Strain, Subgroup A Plasmid DNA (pFRA). J. Virol. 72: 7048-7056 [Abstract] [Full Text]  
• Starkey, C. R., Lobelle-Rich, P. A., Granger, S., Brightman, B. K., Fan, H., Levy, L. S. (1998). Tumorigenic Potential of a Recombinant Retrovirus Containing Sequences from Moloney Murine Leukemia Virus and Feline Leukemia Virus. J. Virol. 72: 1078-1084 [Abstract] [Full Text]